Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Contraception and Contraceptive Drugs

Free Subscription Articles published in JAMA Retrieve available abstracts of 35 articles: HTML format

Single Articles

October 2026
1. ANDERER S
   WHO Broadens Guidance for Recommended Contraceptives.
   JAMA. 2026 Oct 16. doi: 10.1001/jama.2026.20023.
   PubMed    
   
   
   May 2026
2. RODRIGUEZ MI, Fuerst M, Schrote K
   Management of Spontaneous Abortion Among Commercially Insured Individuals in the United States After Dobbs v Jackson.
   JAMA. 2026 May 18:e266344. doi: 10.1001/jama.2026.6344.
   PubMed     Abstract available
   
   
   January 2026
3. DILEK S, Rosen J, Levashkevich A, Sharfstein JM, et al
   The US Food and Drug Administration's Regulation of Mifepristone.
   JAMA. 2026 Jan 12. doi: 10.1001/jama.2025.23091.
   PubMed     Abstract available
   
   
   November 2025
4. PANT S
   ACOG Issues Contraception Access Guidance.
   JAMA. 2025 Nov 7. doi: 10.1001/jama.2025.19726.
   PubMed    
   
   
   June 2025
5. MEAIDI A, Yonis HGH
   Hormonal Contraception and Venous Thromboembolism Risk-Reply.
   JAMA. 2025 Jun 12. doi: 10.1001/jama.2025.5021.
   PubMed    
   
   
   
6. LIDEGAARD O
   Hormonal Contraception and Venous Thromboembolism Risk.
   JAMA. 2025 Jun 12. doi: 10.1001/jama.2025.5018.
   PubMed    
   
   
   May 2025
7. AS-SANIE S, Mackenzie SC, Morrison L, Schrepf A, et al
   Endometriosis: A Review.
   JAMA. 2025 May 5. doi: 10.1001/jama.2025.2975.
   PubMed     Abstract available
   
   
   February 2025
8. YONIS HGH, Morch LS, Lokkegaard E, Kragholm K, et al
   Contemporary Hormonal Contraception and Risk of Venous Thromboembolism.
   JAMA. 2025 Feb 10:e2428778. doi: 10.1001/jama.2024.28778.
   PubMed    
   
   
   
9. ANDERER S
   Permanent Contraception Procedures Increase Among Young Adults Post Dobbs.
   JAMA. 2025 Feb 7. doi: 10.1001/jama.2025.0241.
   PubMed    
   
   
   October 2024
10. GROSSMAN D, Kinsey ET
    Over-the-Counter Oral Contraceptives.
    JAMA. 2024 Oct 9. doi: 10.1001/jama.2024.16474.
    PubMed    
    
    
    September 2024
11. LYNCH HF, Lurie P, Cohen IG
    Checks and Balances on FDA's Authority.
    JAMA. 2024;332:705-706.
    PubMed    
    
    
    August 2024
12. GOODWIN MB, Whelan AM, Gostin LO
    Food and Drug Administration v Alliance for Hippocratic Medicine-A Cautious Win for Reproductive Health Care and FDA Authority.
    JAMA. 2024;332:453-454.
    PubMed    
    
    
    July 2024
13. QATO DM, Guadamuz JS, Myerson R
    Changes in Emergency Contraceptive Fills After Massachusetts' Statewide Standing Order.
    JAMA. 2024 Jul 2:e2411715. doi: 10.1001/jama.2024.11715.
    PubMed    
    
    
    June 2024
14. RALPH LJ, Baba CF, Biggs MA, McNicholas C, et al
    Comparison of No-Test Telehealth and In-Person Medication Abortion.
    JAMA. 2024 Jun 24:e2410680. doi: 10.1001/jama.2024.10680.
    PubMed     Abstract available
    
    
    
15. HARRIS E
    Receiving Abortion Medication Through Mail Was Safe, Effective.
    JAMA. 2024 Jun 7. doi: 10.1001/jama.2024.10330.
    PubMed    
    
    
    May 2024
16. MANSON JE, Crandall CJ, Rossouw JE, Chlebowski RT, et al
    The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.
    JAMA. 2024;331:1748-1760.
    PubMed     Abstract available
    
    
    
17. ESPEY E, Hailstorks T, Hofler L
    Understanding the Impacts of the Supreme Court Case FDA v Alliance for Hippocratic Medicine.
    JAMA. 2024;331:1529-1530.
    PubMed    
    
    
    April 2024
18. HARRIS E
    Over-the-Counter Birth Control Pill Now Available in US.
    JAMA. 2024;331:1354.
    PubMed    
    
    
    
19. HARRIS E
    Use of Progestogen Tied to Higher Chance of Benign Brain Tumor.
    JAMA. 2024 Apr 19. doi: 10.1001/jama.2024.5923.
    PubMed    
    
    
    March 2024
20. FERNANDEZ LYNCH H, Kesselheim AS
    The FDA in the Crosshairs-Science, Politics, and Abortion.
    JAMA. 2024 Mar 25. doi: 10.1001/jama.2024.2229.
    PubMed    
    
    
    
21. AIKEN ARA, Wells ES, Gomperts R, Scott JG, et al
    Provision of Medications for Self-Managed Abortion Before and After the Dobbs v Jackson Women's Health Organization Decision.
    JAMA. 2024 Mar 25:e244266. doi: 10.1001/jama.2024.4266.
    PubMed     Abstract available
    
    
    October 2023
22. MEEGAN MA
    Explaining the Fifth Circuit Court of Appeals Ruling on Mifepristone Access.
    JAMA. 2023 Oct 26. doi: 10.1001/jama.2023.21591.
    PubMed    
    
    
    September 2023
23. HARRIS E
    Blot Clot Risk Higher When Pain Relievers Used With Hormonal Contraception.
    JAMA. 2023 Sep 20. doi: 10.1001/jama.2023.17823.
    PubMed    
    
    
    
24. FLEURANT E, Mokashi M, Simon MA
    Over-the-Counter Progestin-Only Oral Contraceptives.
    JAMA. 2023 Sep 15. doi: 10.1001/jama.2023.17781.
    PubMed    
    
    
    August 2023
25. HARRIS E
    FDA Greenlights First Over-the-Counter Oral Birth Control.
    JAMA. 2023;330:585.
    PubMed    
    
    
    July 2023
26. JUGL S, Winterstein AG
    Ectopic Pregnancy Risk and Levonorgestrel-Releasing Intrauterine Systems.
    JAMA. 2023;330:378.
    PubMed    
    
    
    
27. MEAIDI A, Torp-Pedersen C, Morch LS
    Ectopic Pregnancy Risk and Levonorgestrel-Releasing Intrauterine Systems-Reply.
    JAMA. 2023;330:378-379.
    PubMed    
    
    
    
28. BOOS EW, Horta M, Thompson I, Dusetzina SB, et al
    Trends in the Use of Mifepristone for Medical Management of Early Pregnancy Loss From 2016 to 2020.
    JAMA. 2023 Jul 21. doi: 10.1001/jama.2023.13628.
    PubMed    
    
    
    
29. BRANDI K, Upadhya KK, Teal SB
    Over-the-Counter Oral Contraception as an Opportunity to Reduce Contraceptive Access Inequity.
    JAMA. 2023 Jul 14. doi: 10.1001/jama.2023.10825.
    PubMed    
    
    
    June 2023
30. RUBIN R
    Over-the-Counter Birth Control Pill Could Be Available in the US by Year's End.
    JAMA. 2023;329:2009-2010.
    PubMed    
    
    
    
31. GLUCK AR
    The Mifepristone Case and the Legitimacy of the FDA.
    JAMA. 2023 Jun 2. doi: 10.1001/jama.2023.8712.
    PubMed    
    
    
    April 2023
32. AARON DG, Brown TR, Sinha MS
    Court Intrusion Into Science and Medicine-the Mifepristone Decisions.
    JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.7790.
    PubMed    
    
    
    March 2023
33. MEAIDI A, Torp-Pedersen C, Lidegaard O, Morch LS, et al
    Ectopic Pregnancy Risk in Users of Levonorgestrel-Releasing Intrauterine Systems With 52, 19.5, and 13.5 mg of Hormone.
    JAMA. 2023;329:935-937.
    PubMed    
    
    
    
34. AVERBACH S, Kully G, Hinz E, Dey A, et al
    Early vs Interval Postpartum Intrauterine Device Placement: A Randomized Clinical Trial.
    JAMA. 2023;329:910-917.
    PubMed     Abstract available
    
    
    
35. HARRIS E
    On-Demand Male Contraceptive Compound Promising in Mouse Study.
    JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2888.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum